Europe Transfection Reagents and Equipment Market
The Europe Transfection Reagents and Equipment Market size was valued at US$ 306.04 Mn in 2022 and is projected to reach US$ 555.46 Mn by 2030, growing at a CAGR of 7.7% during 2022 - 2030.
Report Coverage
- Product: Reagents and Instruments
- Method: Viral Methods, Non Viral Methods, Hybrid Methods
- End User: Academics & Research Institutes and Pharmaceutical & Biotechnology Companies
US$ 306.04 Mn
Market size in 2022
US$ 555.46 Mn
Market Size by 2030
7.7%
CAGR, 2022 - 2030
2023-2030
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Transfection Reagents and Equipment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Transfection Reagents and Equipment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Transfection Reagents and Equipment Market Regional Analysis
6.2 Europe Transfection Reagents and Equipment Market Revenue 2020-2030 (US$ Million)
6.3 Europe Transfection Reagents and Equipment Market Forecast Analysis
7. Europe Transfection Reagents and Equipment Market Analysis – by Product
7.1 Reagents and Instruments
- 7.1.1 Overview
- 7.1.2 Reagents and Instruments: Europe Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Transfection Reagents and Equipment Market Analysis – by Method
8.1 Viral Methods
- 8.1.1 Overview
- 8.1.2 Viral Methods: Europe Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Non Viral Methods
- 8.2.1 Overview
- 8.2.2 Non Viral Methods: Europe Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Hybrid Methods
- 8.3.1 Overview
- 8.3.2 Hybrid Methods: Europe Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Transfection Reagents and Equipment Market Analysis – by End User
9.1 Academics & Research Institutes and Pharmaceutical & Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Academics & Research Institutes and Pharmaceutical & Biotechnology Companies : Europe Transfection Reagents and Equipment Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Transfection Reagents and Equipment Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Transfection Reagents and Equipment Market Breakdown, by Key Country, 2023 and 2030 (%)
- 10.2.1.1 Europe Transfection Reagents and Equipment Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 UK: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.1.2 UK: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.1.3 UK: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Germany: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.2.2 Germany: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.2.3 Germany: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.2.1.3 France: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 France: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.3.2 France: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.3.3 France: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.4.1 Russia: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.4.2 Russia: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.4.3 Russia: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.5.1 Italy: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.5.2 Italy: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.5.3 Italy: Europe Transfection Reagents and Equipment Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Transfection Reagents and Equipment Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Transfection Reagents and Equipment Market Breakdown, by Product
- 10.2.1.6.2 Rest of Europe: Europe Transfection Reagents and Equipment Market Breakdown, by Method
- 10.2.1.6.3 Rest of Europe: Europe Transfection Reagents and Equipment Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Promega Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bio-Rad Laboratories Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Mirus Bio LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 QIAGEN NV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merck KGaA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Lonza Group AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 MaxCyte Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Polyplus-Transfection SA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
